biological_process

SENESCENCE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SENESCENCE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2579Connections

30Hypotheses

1Analyses

50Outgoing

50Incoming

17Experiments

8Debates

No summary available yet.

View on Wiki →

No AI portrait yet

🧬 Biological Process Info

Name	SENESCENCE
Key Genes/Proteins	ABCA1, AKT, ALPHA-SYNUCLEIN, AMYLOID
Related Diseases	ANGIOGENESIS

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Cellular Senescence in Corticobasal Syndrome

mechanism · 2595 words

→

Pathway Diagram

graph TD
    SENESCENCE["SENESCENCE"] -->|"contributes to"| TUMOR["TUMOR"]
    SENESCENCE["SENESCENCE"] -->|"causes"| STING["STING"]
    SENESCENCE["SENESCENCE"] -->|"expressed in"| T_CELL["T CELL"]
    SENESCENCE["SENESCENCE"] -->|"expressed in"| T_CELLS["T CELLS"]
    SENESCENCE["SENESCENCE"] -->|"associated"| T_CELL_1["T CELL"]
    SENESCENCE["SENESCENCE"] -->|"associated"| T_CELLS_2["T CELLS"]
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"associated"| SENESCENCE["SENESCENCE"]
    NEURODEGENERATION["NEURODEGENERATION"] -->|"associated"| SENESCENCE["SENESCENCE"]
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"associated"| SENESCENCE["SENESCENCE"]
    NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated"| SENESCENCE["SENESCENCE"]
    style SENESCENCE fill:#5d4400,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0

Outgoing (594)

Target	Relation	Type	Str
Telomere	associated_with	pathway	1.00
Dna Repair	regulates	pathway	1.00
Autophagy	activates	pathway	1.00
Inflammation	associated_with	disease	1.00
Alzheimer	associated_with	disease	1.00
Autophagy	associated_with	pathway	1.00
Oxidative Stress	activates	pathway	1.00
Apoptosis	activates	pathway	1.00
Cell Cycle	associated_with	pathway	1.00
Oxidative Stress	associated_with	pathway	1.00
Apoptosis	regulates	pathway	1.00
Autophagy	regulates	pathway	1.00
Cell Cycle	regulates	pathway	1.00
Differentiation	activates	pathway	1.00
Immune Response	activates	pathway	1.00
Nf-Κb	activates	pathway	1.00
Cell Cycle	activates	pathway	1.00
Epigenetic	associated_with	pathway	1.00
Epigenetic	activates	pathway	1.00
Epigenetic	inhibits	pathway	0.95
aging	promotes	process	0.95
hypersecretory state	causes	process	0.95
cell-cycle arrest	causes	process	0.95
chronic kidney disease	associated_with	disease	0.95
SASP	causes	process	0.95
Aging	associated_with	process	0.95
Inflammation	therapeutic_target	disease	0.95
Cellular Aging	involved_in	process	0.95
kidney aging	regulates	process	0.92
NEUROINFLAMMATION	associated_with	entity	0.90
cancer	associated_with	disease	0.90
Cellular Damage	causes	phenotype	0.90
Leukemia Cell Resistance	associated_with	phenotype	0.90
Senescence-Associated Secretory Phenotype	mediates	phenotype	0.90
Cell Proliferation	inhibits	process	0.90
Mtor	activates	pathway	0.90
Stem Cell	inhibits	pathway	0.90
Epigenetic	regulates	pathway	0.90
Stem Cell	associated_with	pathway	0.90
Pi3K/Akt	activates	pathway	0.90
Apoptosis	inhibits	pathway	0.90
aging	downstream_of	process	0.88
adaptive responses	inhibits	process	0.85
chronic disease	associated_with	disease	0.85
senescence-associated disease	causes	disease	0.85
skin photoaging	associated_with	disease	0.85
Cancer	associated_with	disease	0.85
cardiovascular diseases	causes	disease	0.85
Cancer Progression	contributes_to	process	0.85
Cardiovascular Disease	risk_factor_for	disease	0.85

Incoming (1985)

Source	Relation	Type	Str
CANCER	activates	gene	1.00
INFLAMMATION	regulates	gene	1.00
Cardiovascular	associated_with	disease	1.00
CGAS-STING	activates	gene	1.00
NEURODEGENERATION	associated_with	gene	1.00
AGING	therapeutic_target	gene	1.00
DNA	activates	gene	1.00
AGING	inhibits	gene	1.00
Neurodegeneration	activates	disease	1.00
NEURODEGENERATIVE DISEASES	associated_with	gene	1.00
ALZHEIMER'S DISEASE	associated_with	gene	1.00
AGING	regulates	gene	1.00
INFLAMMATION	activates	gene	1.00
CANCER	therapeutic_target	gene	1.00
GENES	activates	gene	1.00
P53	inhibits	gene	1.00
Als	associated_with	disease	1.00
Cancer	associated_with	disease	1.00
CANCER	regulates	gene	1.00
INFLAMMATION	inhibits	gene	1.00
AUTOPHAGY	activates	gene	1.00
Tumor	activates	disease	1.00
INFLAMMATION	therapeutic_target	gene	1.00
NEURODEGENERATION	activates	gene	1.00
CYTOKINES	activates	gene	1.00
Inflammation	therapeutic_target	disease	1.00
AGING	activates	gene	1.00
IL-6	activates	gene	1.00
APOPTOSIS	regulates	gene	1.00
APOPTOSIS	activates	gene	1.00
P53	activates	gene	1.00
APOPTOSIS	inhibits	gene	1.00
AUTOPHAGY	regulates	gene	1.00
Aging	therapeutic_target	disease	1.00
GENES	regulates	gene	1.00
Als	therapeutic_target	disease	1.00
Tumor	inhibits	disease	1.00
Cancer	therapeutic_target	disease	1.00
Tumor	associated_with	disease	1.00
CANCER	associated_with	gene	1.00
GENES	associated_with	gene	1.00
Aging	associated_with	disease	1.00
DNA	inhibits	gene	1.00
MITOCHONDRIAL DYSFUNCTION	associated_with	gene	1.00
MITOCHONDRIA	regulates	gene	1.00
Inflammation	associated_with	disease	1.00
Als	activates	disease	1.00
Cancer	regulates	disease	1.00
P53	regulates	gene	1.00
ROS	activates	gene	1.00

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc	0.893	neurodegeneration	Gene expression changes in aging mouse b
Microglial Senescence Prevention via TREM2/SASP Axis	0.837	neurodegeneration	View
TREM2 Deficiency Drives Microglial Senescence via Lipid Meta	0.818	neurodegeneration	What molecular mechanisms drive microgli
Oligodendrocyte Precursor Cell Senescence in White Matter Di	0.769	-	Senescent cell clearance as neurodegener
Senescence-Activated NAD+ Depletion Rescue	0.755	neurodegeneration	Senolytic therapy for age-related neurod

TREM2-SIRT1 Metabolic Senescence Circuit in Microglial Aging	0.744	neurodegeneration	Gene expression changes in aging mouse b
Senescence-Associated Myelin Lipid Remodeling	0.732	neurodegeneration	Senolytic therapy for age-related neurod
Senescence-Induced Lipid Peroxidation Spreading	0.730	neurodegeneration	Senolytic therapy for age-related neurod
APOE4-driven pericyte injury/senescence is an upstream drive	0.720	neurodegeneration	Does pericyte senescence drive BBB break
H3: APOE4 Impairs Cholesterol Trafficking, Triggering Astroc	0.720	neurodegeneration	Do APOE4-driven senescent astrocytes cau
NLRP3 Inflammasome Lock Perpetuates Senescence-Associated In	0.720	neurodegeneration	What molecular mechanisms drive microgli
Metabolic Reprogramming to Reverse Senescence	0.720	-	Senescent cell clearance as neurodegener
H4: Senomorphic Compounds Preserve Astrocyte Function While	0.710	neurodegeneration	Do APOE4-driven senescent astrocytes cau
TREM2-ASM Crosstalk in Microglial Lysosomal Senescence	0.705	neurodegeneration	Gene expression changes in aging mouse b
NAD+ Decline and SIRT1 Deficiency Drive Epigenetic Reprogram	0.700	neurodegeneration	What molecular mechanisms drive microgli
cGAS-STING Senescence Circuit Disruption	0.691	neurodegeneration	Gene expression changes in aging mouse b
mTORC1 Reactivation as Autophagy-Senescence Divergence Point	0.682	molecular biology	What is the optimal therapeutic window t
NMN Adenosine Transport Enhancement for Cortical Neuron Sene	0.680	neurodegeneration	-
DRP1 S616 Hyperphosphorylation and MFN2 Downregulation Creat	0.680	neurodegeneration	-
Metabolic Checkpoint Failure in NG2+ Oligodendrocyte Progeni	0.680	neurodegeneration	-
TREM2-Mediated Cholesterol Dysregulation in Microglial Senes	0.666	neurodegeneration	Gene expression changes in aging mouse b
GDF15-GFRAL Axis as Systemic Autophagy-Senescence Integrator	0.659	molecular biology	What is the optimal therapeutic window t
Radiation drives pericyte senescence through lysosome acidif	0.652	neurodegeneration	What specific autophagy pathways are def
Apoptosis-Senescence Decision Point Intervention	0.649	-	Senescent cell clearance as neurodegener
TREM2-Driven Senescence Biomarker Index for Predicting Neuro	0.642	neurodegeneration	Gene expression changes in aging mouse b
Amyloid-beta induces secondary pericyte senescence after con	0.640	neurodegeneration	Does pericyte senescence drive BBB break
Pericyte senescence is sufficient to weaken the BBB even wit	0.630	neurodegeneration	Does pericyte senescence drive BBB break
APOE4-Driven Astrocyte Senescence as Primary Target	0.629	-	Senescent cell clearance as neurodegener
Autophagy-Senescence Axis Therapeutic Window	0.624	-	Senescent cell clearance as neurodegener
TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio	0.000	ALS	What are the mechanisms by which microgl

Mentioning Analyses (1)

Scientific analyses that reference this entity

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.769

Experiments (17)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
E2F coordination of G2/M transcriptional program	exploratory		0.750	0.00	endocycling mammalian cells	proposed	N/A
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
Microglial Aging and Immune Memory in Neurodegeneration — Training the	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,960,000
Normal Aging to Alzheimer's Disease Transition Trigger — Identifying t	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,280,000
Peroxisomal Dysfunction Validation in Parkinson's Disease	validation	Parkinson's Disease	0.400	0.50	human	proposed	$2,280,000
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
Sirtuin Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Sirtuin Pathway Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Proposed experiment from debate on Senolytics targeting p16/p21+ senes	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
Proposed experiment from debate on Microglia activate astrocytes via I	falsification	Neuroinflammation	0.400	0.50	cell_line	completed	$80,000
Iron Dyshomeostasis in MSA Pathogenesis Experiment	validation	Neurodegeneration	0.400	0.50	human	proposed	$2,280,000
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,100,000
Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe	clinical	Neurodegeneration	0.400	0.50	in_silico	proposed	$180,000
Ferroptosis Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Peroxisome Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Regulated Necrosis Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Traumatic Brain Injury and Alzheimer's Disease Relationship	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$3,000,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Klebsiella pneumoniae Induces Ferroptosis and Lactation Dysfunction in Bovine Ma [PMID:40937759]	Mao P, Wang Z, Duan J, Dong P, Yuan C, L	J Agric Food Chem	2025	1
Targeting ferroptosis: novel therapeutic approaches and intervention strategies [PMID:41425591]	Luo Y, Long M, Wu X, Zeng L	Front Immunol	2025	1
Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and De [PMID:38580317]	Velma GR, Krider IS, Alves ETM, Courey J	J Med Chem	2024	1
Copy number deletion of PLA2G4A affects the susceptibility and clinical phenotyp [PMID:38816399]	Gao Z, Guo X, Sun Z, Wu S, Wang Q, Huang	Schizophrenia (Heidelb)	2024	1
Trimetazidine attenuates Ischemia/Reperfusion-Induced myocardial ferroptosis by [PMID:39134283]	Tan M, Yin Y, Chen W, Zhang J, Jin Y, Zh	Biochem Pharmacol	2024	1
NAD(+) metabolism, stemness, the immune response, and cancer. [PMID:33384409]	Navas LE, Carnero A	Signal Transduct Target Ther	2021	1
NAD metabolism fuels human and mouse intestinal inflammation. [PMID:28877980]	Gerner RR, Klepsch V, Macheiner S, Arnha	Gut	2018	1
NAD+ and sirtuins in aging and disease. [PMID:24786309]	Imai S, Guarente L	Trends Cell Biol	2014	1
Lipoprotein-associated and secreted phospholipases A₂ in cardiovascular disease: [PMID:21098459]	Mallat Z, Lambeau G, Tedgui A	Circulation	2010	1
Phospholipase A2 regulation of bovine endometrial (BEND) cell prostaglandin prod [PMID:18811942]	Godkin JD, Roberts MP, Elgayyar M, Guan	Reprod Biol Endocrinol	2008	1
Discovery of a glycosylated colchicine derivative as a neuroprotective agent for [PMID:41455281]	["Jash M", "Gupta S", "Garg S", "Khan J"	European journal of medicinal	2026	0
The NADPH oxidase inhibitor Vas2870 prevents myocyte ferroptosis and improves ca [PMID:41671579]	Wang J, Li CM, Yang B, Tantai RN, Guo HX	British journal of pharmacolog	2026	0
Arachidonic acid analog AACOCF3 suppresses cPLA2-negative NSCLC cell proliferati [PMID:41544858]	Wang H, Wen Z, Jia Y, Tong X, Wang W et	Biochem Pharmacol	2026	0
Opioid-induced transcriptional reprogramming of cerebrospinal fluid immune cells [PMID:41674808]	Acharya A, Ambikan AT, Neogi U, Lamberty	Res Sq	2026	0
Siah2 is a lipid-mediated metabolic sensor in adipose tissue macrophage. [PMID:41690475]	Dang TN, Ghosh B, Panta PR, Taylor JM, K	J Lipid Res	2026	0
From association to mechanism: Prenatal PFAS Co-exposures induces fetal neural t [PMID:41485332]	Chen Y, Cheng Q, Yang C, Li S, Lin H, Li	Journal of hazardous materials	2026	0
Silencing myeloid cell leukemia-1 improves apoptotic and ferroptotic responses i [PMID:41540498]	Fang F, Xu Q, Shen S, Wang S, Bao C	European journal of medical re	2026	0
Modification of the dermal matrix by senescence associated lipids and its functi [PMID:41690117]	["Jelleschitz S", "Kremslehner C", "Nage	Redox biology	2026	0
Traditional Chinese Herbal Formula XuMingZhuSan Alleviates Neuronal Ferroptosis [PMID:41822239]	Liu X, Wang C, Han L, Xiao Y, Yu H, Hu Z	Food science & nutrition	2026	0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025	0

Debates (8)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

closed · Rounds: 4 · Score: 0.75 · 2026-04-16

Senescent cell clearance as neurodegeneration therapy

closed · Rounds: 3 · Score: 0.95 · 2026-04-04

Related Research

Hypotheses and analyses mentioning SENESCENCE in their description or question text

TREM2-SIRT1 Metabolic Senescence Circuit in Microglial Aging

Score: 0.744 · neurodegeneration · 2026-04-12

**Molecular Mechanism and Rationale** The TREM2-SIRT1 metabolic senescence circuit represents a critical regulatory net

Senescence-Associated Myelin Lipid Remodeling

Score: 0.732 · neurodegeneration · 2026-04-02

## Mechanistic Overview Senescence-Associated Myelin Lipid Remodeling starts from the claim that modulating PLA2G6/PLA2G

Senescence-Induced Lipid Peroxidation Spreading

Score: 0.730 · neurodegeneration · 2026-04-02

## Mechanistic Overview Senescence-Induced Lipid Peroxidation Spreading starts from the claim that modulating GPX4/SLC7A

APOE4-driven pericyte injury/senescence is an upstream driver of early BBB break

Score: 0.720 · neurodegeneration · 2026-04-25

In APOE4 contexts, reduced LRP1 signaling in PDGFRB+ pericytes permits activation of the PPIA/CypA-MMP9 axis, leading to

H3: APOE4 Impairs Cholesterol Trafficking, Triggering Astrocyte Senescence

Score: 0.720 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The APOE4 isoform exhibits fundamentally altered structural and functional proper

NLRP3 Inflammasome Lock Perpetuates Senescence-Associated Inflammasome Phenotype

Score: 0.720 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The NLRP3 (NACHT, LRR and PYD domains-containing protein 3) inflammasome represen

Metabolic Reprogramming to Reverse Senescence

Score: 0.720 · unknown disease · 2026-04-16

# Metabolic Reprogramming to Reverse Senescence in Neurodegeneration: A Mechanistic Hypothesis ## The Senescence Conund

H4: Senomorphic Compounds Preserve Astrocyte Function While Reversing Senescence

Score: 0.710 · neurodegeneration · 2026-04-22

## Mechanistic Overview H4: Senomorphic Compounds Preserve Astrocyte Function While Reversing Senescence starts from the

TREM2-ASM Crosstalk in Microglial Lysosomal Senescence

Score: 0.705 · neurodegeneration · 2026-04-12

## Mechanistic Overview TREM2-ASM Crosstalk in Microglial Lysosomal Senescence starts from the claim that modulating SMP

NAD+ Decline and SIRT1 Deficiency Drive Epigenetic Reprogramming Toward Senescen

Score: 0.700 · neurodegeneration · 2026-04-22

## **Molecular Mechanism and Rationale** The molecular foundation of this hypothesis centers on the intricate relations

cGAS-STING Senescence Circuit Disruption

Score: 0.691 · neurodegeneration · 2026-04-04

## Molecular Mechanism and Rationale The cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) path

mTORC1 Reactivation as Autophagy-Senescence Divergence Point Marker

Score: 0.682 · molecular biology · 2026-04-21

## Mechanistic Overview mTORC1 Reactivation as Autophagy-Senescence Divergence Point Marker starts from the claim that m